Correction: Nutritional status and drug resistance in EGFR-mutant NSCLC: a retrospective cohort study on almonertinib efficacy.
APA
Wu C, Li Y, et al. (2026). Correction: Nutritional status and drug resistance in EGFR-mutant NSCLC: a retrospective cohort study on almonertinib efficacy.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-025-04898-y
MLA
Wu C, et al.. "Correction: Nutritional status and drug resistance in EGFR-mutant NSCLC: a retrospective cohort study on almonertinib efficacy.." Naunyn-Schmiedeberg's archives of pharmacology, 2026.
PMID
41781656
같은 제1저자의 인용 많은 논문 (5)
- Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia.
- The molecular mechanism of IGF2BP3 promoting the malignant progression of lung cancer.
- SMARCA4 promotes lineage plasticity and enzalutamide resistance in prostate cancer by regulating PROX1 via H3K27 acetylation.
- Discovery of Bufalin as a Molecular Glue Degrader of NCAPG to Inhibit the Proliferation of Hepatoma Cells.
- Laparoscopic-Assisted Microwave Ablation for Splenic Hemangioma: A Case Report and Literature Review.